These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33383170)
1. Impact of incorporated drugs on material properties of amorphous solid dispersions. Flügel K; Schmidt K; Mareczek L; Gäbe M; Hennig R; Thommes M Eur J Pharm Biopharm; 2021 Feb; 159():88-98. PubMed ID: 33383170 [TBL] [Abstract][Full Text] [Related]
2. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion. Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685 [TBL] [Abstract][Full Text] [Related]
3. The Influence of the Polymer Type on the Quality of Newly Developed Oral Immediate-Release Tablets Containing Amiodarone Solid Dispersions Obtained by Hot-Melt Extrusion. Fița AC; Secăreanu AA; Musuc AM; Ozon EA; Sarbu I; Atkinson I; Rusu A; Mati E; Anuta V; Pop AL Molecules; 2022 Oct; 27(19):. PubMed ID: 36235137 [TBL] [Abstract][Full Text] [Related]
4. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance. Indulkar AS; Lou X; Zhang GGZ; Taylor LS Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846 [TBL] [Abstract][Full Text] [Related]
5. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate. Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228 [TBL] [Abstract][Full Text] [Related]
6. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach. Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898 [TBL] [Abstract][Full Text] [Related]
7. Impact of structural relaxation on mechanical properties of amorphous polymers. Flügel K; Hennig R; Thommes M Eur J Pharm Biopharm; 2020 Sep; 154():214-221. PubMed ID: 32702377 [TBL] [Abstract][Full Text] [Related]
8. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology. Tripathi D; B H MP; Sahoo J; Kumari J Recent Adv Drug Deliv Formul; 2024; 18(2):79-99. PubMed ID: 38062659 [TBL] [Abstract][Full Text] [Related]
10. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284 [TBL] [Abstract][Full Text] [Related]
11. 3D-printed tablets using a single-step hot-melt pneumatic process for poorly soluble drugs. Kim SJ; Lee JC; Ko JY; Lee SH; Kim NA; Jeong SH Int J Pharm; 2021 Feb; 595():120257. PubMed ID: 33486029 [TBL] [Abstract][Full Text] [Related]
12. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets. Solanki NG; Kathawala M; Serajuddin ATM J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437 [TBL] [Abstract][Full Text] [Related]
13. The effects of polymer carrier, hot melt extrusion process and downstream processing parameters on the moisture sorption properties of amorphous solid dispersions. Feng X; Vo A; Patil H; Tiwari RV; Alshetaili AS; Pimparade MB; Repka MA J Pharm Pharmacol; 2016 May; 68(5):692-704. PubMed ID: 26589107 [TBL] [Abstract][Full Text] [Related]
14. Downstream processing of amorphous solid dispersions into orodispersible tablets. Kokott M; Klinken S; Breitkreutz J; Wiedey R Int J Pharm; 2023 Jan; 631():122493. PubMed ID: 36528189 [TBL] [Abstract][Full Text] [Related]
15. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration. Yang B; Wei C; Yang Y; Wang Q; Li S Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692 [TBL] [Abstract][Full Text] [Related]
16. Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles. Hanada N; Higashi K; Zhao Z; Ueda K; Moribe K Int J Pharm; 2023 Jun; 640():122959. PubMed ID: 37086931 [TBL] [Abstract][Full Text] [Related]
17. Quercetin amorphous solid dispersions prepared by hot melt extrusion with enhanced solubility and intestinal absorption. Shi X; Fan N; Zhang G; Sun J; He Z; Li J Pharm Dev Technol; 2020 Apr; 25(4):472-481. PubMed ID: 31909684 [TBL] [Abstract][Full Text] [Related]